An Oregon Health & Science University researcher has co-authored an international study that revealed a drug approved to prevent rejection in organ transplant patients helped treat a rare lung disease in women.

The life-threatening disease has no cure and, until now, no known treatment. The clinical trial of the drug - called sirolimus - was the first randomized, controlled study designed to develop a therapy for the lung disease, lymphangioleiomyomatosis, or LAM. LAM is a progressive, cystic lung disease that occurs almost exclusively in women...